Finally, we identified the PLOD1-related signaling pathways and suggested that PLOD1 acted as a cancer-promoting factor in tumor progression, providing a potential prognostic biomarker and therapeutic target for glioma patients. This evidence concerns the gene PLOD1 and neoplasm.